600276.SHG Jiangsu Hengrui Medicine Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
52.22 CNY
Close of Nov 5, 2026
41.89 65.83
Market cap
CNY 333B
P/E
37.5x
P/B
4.90x
ROE
13.8%
Dividend yield
0.38%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600276.SHG undervalued?

Graham number
Price52.22
Graham value18.29
Premium185.6%

600276.SHG trades 185.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jiangsu Hengrui Medicine Co Ltd fundamental analysis

No fundamental analysis for Jiangsu Hengrui Medicine Co Ltd yet.

Jiangsu Hengrui Medicine Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jiangsu Hengrui Medicine Co Ltd

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is …

Full company profile